Ke Xu (K Xu)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 23

Top Topics

Aortic Dissection

Multiple Myeloma

Respiratory Failure

Top Venues

Journal of hematopathology

British journal of haematology

Clinical hematology international

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Ke Xu, Shweta Gupta, Eleanor Kaffo, Robert Baker, Elisabeth Nacheva, Jenny O'Nions, Andrew J Wilson, Rajeev Gupta
The use of targeted ribonucleic acid (RNA)-sequencing assay in the diagnostic evaluation of acute myeloid leukaemia (AML). Journal of hematopathology (2024)
Ke Xu, Charalampia Kyriakou
Extramedullary myeloma progressed to plasmablastic myeloma. Clinical hematology international 6 (1) (2024)
Ke Xu, Charalampia Kyriakou
Extramedullary myeloma progressed to plasmablastic myeloma. Clinical hematology international 6 (1) (2024)
Ke Xu, Elisabeth Nacheva
Secondary plasma cell leukaemia (PCL) with plasmablastic morphology. Journal of hematopathology 17 (2) (2024)
Ke Xu, Elisabeth Nacheva
Secondary plasma cell leukaemia (PCL) with plasmablastic morphology. Journal of hematopathology (2024)
Ke Xu, Elisabeth Nacheva
Secondary plasma cell leukaemia (PCL) with plasmablastic morphology. Journal of hematopathology 17 (2) (2024)
Ke Xu, Elisabeth Nacheva
Secondary plasma cell leukaemia (PCL) with plasmablastic morphology. Journal of hematopathology 17 (2) (2024)
Ke Xu, Shweta Gupta, Eleanor Kaffo, Robert Baker, Elisabeth Nacheva, Jenny O'Nions, Andrew J Wilson, Rajeev Gupta
The use of targeted ribonucleic acid (RNA)-sequencing assay in the diagnostic evaluation of acute myeloid leukaemia (AML). Journal of hematopathology 17 (3) (2024)
Sarrah Tayabali, Robert Baker, Elisabeth Nacheva, Jenny O'Nions, Rajeev Gupta, Andrew J Wilson, Ke Xu
The use of leukaemia Q-fusion gene screening assay (Q30) in the diagnostic evaluation of acute myeloid leukaemia (AML). Journal of hematopathology 17 (1) (2023)
S Asher, R Shah, S Ings, J Horder, F Newrick, George Nesr, R Kesse-Adu, Matthew Streetly, Sara Trompeter, L Lee, B Wisniowski, S Mahmood, Ke Xu, X Papanikalaou, Annabel McMillan, R Popat, K Yong, Jonathan Sive, C Kyriakou, N Rabin
Haematopoietic stem cell mobilisation followed by high-dose chemotherapy and autologous stem cell transplantation for patients with sickle cell disease and myeloma. British journal of haematology (2023)
Ke Xu, Elisabeth Nacheva
Acute myeloid leukaemia (AML) with KMT2A rearrangement presented with haemophagocytic lymphohistiocytosis (HLH). International journal of laboratory hematology (2023)
Ke Xu, Anna Childerhouse, Rajeev Gupta
Mast cell leukaemia progressed from myelodysplastic syndrome after acquiring KIT mutation. International journal of laboratory hematology (2023)
Ke Xu, Elisabeth Nacheva
Chronic myeloid leukaemia (CML) presenting in B-lymphoblastic crisis: a diagnostic challenge. Journal of hematopathology 16 (4) (2023)
Sarrah Tayabali, Robert Baker, Elisabeth Nacheva, Jenny O'Nions, Rajeev Gupta, Andrew J Wilson, Ke Xu
The use of leukaemia Q-fusion gene screening assay (Q30) in the diagnostic evaluation of acute myeloid leukaemia (AML). Journal of hematopathology 17 (1) (2023)
Ke Xu, Elisabeth Nacheva
Chronic myeloid leukaemia (CML) presenting in B-lymphoblastic crisis: a diagnostic challenge. Journal of hematopathology 16 (4) (2023)
George Nesr, Raakhee Shah, Charalampia Kyriakou, Jonathan Sive, Rakesh Popat, Kwee Yong, Brendan Wisniowski, Ke Xu, Ashu Wechalekar, Lydia Lee, Stuart Ings, Xenofon Papanikolaou, Shameem Mahmood, Annabel Mcmillan, Jackie Horder, Fiona Newrick, Jotham Marfil, Louise Ainley, Samir Asher, Simon Cheesman, Neil Rabin
Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience. Leukemia & lymphoma (2023)
Lara Howells, Wei Yee Chan, Emilie Sanchez, Jacqueline Horder, Fiona Newrick, Jotham Marfil, Annabel McMillan, Brendan Wisniowski, Shameem Mahmood, Xenofon Papanikolaou, Lydia Lee, Ashutosh D Wechalekar, Rakesh Popat, Jonathan Sive, Charalampia Kyriakou, Ke Xu, Eleni Nastouli, Kwee L Yong, Neil Rabin
Patients with plasma cell disorders undergoing autologous stem cell transplant retain their humoral response to COVID-19 vaccination but falling titers emphasize the importance of re-vaccination. Leukemia & lymphoma 63 (10) (2022)
Ke Xu, Elisabeth Nacheva
Secondary AML with MLL gene amplification. Blood 140 (2) (2022)
Ke Xu, Anna Childerhouse, Rajeev Gupta
Burkitt leukaemia with B-cell precursor immunophenotype. EJHaem 3 (3) (2022)
Wei Yee Chan, Caitlin MacDonald, Andrew Keenan, Ke Xu, BarbaraJ J Bain, Peter L Chiodini
Severe babesiosis due to Babesia divergens acquired in the United Kingdom. American journal of hematology 96 (7) (2021)
Wei Yee Chan, Emilie Sanchez, Selina J Chavda, Catherine S Y Lecat, Louise Ainley, Ke Xu, Brendan Wisniowski, Shameem Mahmood, Xenofon Papanikolaou, Charalampia Kyriakou, Jonathan Sive, Ashutosh Wechalekar, Rakesh Popat, Neil Rabin, Lydia Lee, Eleni Nastouli, Kwee L Yong
Development of antibody response to SARS-CoV-2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy. British journal of haematology 194 (5) (2021)
Wei Yee Chan, Lara Howells, William Wilson, Emilie Sanchez, Louise Ainley, Selina J Chavda, Emma Dowling, Nuno Correia, Catherine S Y Lecat, Annabel McMillan, Brendan Wisniowski, Shameem Mahmood, Xenofon Papanikolaou, Lydia Lee, Jonathan Sive, Charalampia Kyriakou, Ashutosh Wechalekar, Rakesh Popat, Neil Rabin, Eleni Nastouli, Kwee L Yong, Ke Xu
Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors. British journal of haematology (2021)
Ke Xu, Anna Childerhouse, Ahmed Al-Hassani, Charalampia Kyriakou
Plasmablastic myeloma progressed to plasma cell leukaemia. EJHaem 2 (4) (2021)